Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Price is what you pay. Value is what you keep. In the GLP-1 market right now, those two numbers rarely match, and the gap between them is exactly where most people get burned.
| Brand | Cash Price (med) | Physician Oversight | Lab Testing | Ships In | Best For |
| FormBlends | $299 sema / $349 tirz (per vial, no membership) | Licensed physician, prescription required | HPLC, mass spec, endotoxin per batch | 2-5 days, cold-chain | GLP-1 + peptide stack, cash-pay, transparent pricing |
| Mochi Health | ~$99/mo sema / ~$199/mo tirz | Obesity-medicine specialists | Not published | Varies | Clinical monitoring on a budget |
| Hims & Hers | $249-$399/mo branded | Telehealth clinician | N/A (branded meds) | Fast | Insured or app-first users |
| Ro Body | ~$149/mo + med | Prior-auth team, insurance accepted | N/A | Varies | Insurance navigation |
| Henry Meds | ~$179-$249 month one | Light-touch monitoring | Not published | 24-72 hrs | Speed, convenience |
| PlushCare | ~$19.99/mo + med | Licensed clinicians, insurance accepted | N/A (branded) | Same-day Rx | Quick branded-med access |
| Calibrate | Program fee + med | Coaching-heavy model | N/A | N/A | 12-month insured programs |
| Eden | ~$149/mo sema | Physician review | Not published | Varies | Simple cash model |
| Form Health | ~$299/mo + med + labs | Physician + registered dietitian | N/A | Varies | Premium, high-touch care |

The single clearest differentiator here is transparency. Most programs either bundle medication cost into a membership or publish a vague “starting from” number. FormBlends posts flat per-vial cash prices before you even create an account. Semaglutide runs $299 per vial. Tirzepatide is $349. No monthly platform fee sitting underneath those numbers, no subscription you have to cancel if you stop.
All compounds come out of a licensed pharmacy operating under 503A compounding rules with cGMP standards and FDA inspection history behind it. A prescriber reviews every intake before anything ships. The pharmacy runs three separate quality checks on each batch: high-performance liquid chromatography for purity, mass spectrometry to confirm molecular identity, and pyrogen screening to verify sterility. Purity figures are published per product. Semaglutide clears 99.1%. Tirzepatide comes in at 99.3%. Those aren’t estimated ranges or a single certificate stapled to the whole catalog; they are per-product numbers.
The other piece that actually matters for someone serious about body composition: FormBlends carries both GLP-1 compounds and a full peptide catalog, all under the same prescriber-supervised roof. BPC-157 at $54 a vial. Retatrutide at $389. NAD+ at $89. Most weight-loss platforms are GLP-1 only. Most peptide vendors are research-only, no prescription involved. This is neither. That combination is genuinely uncommon.
Coverage runs across 47 states, and the pharmacy handles cold-chain shipping at no added cost.
One honest note here: compounded medications are not FDA-approved products, and a number of non-GLP-1 peptides in any catalog have human evidence that is still early-stage or preclinical. The science on some of these compounds is promising but not settled. Keep that in mind when building a stack.
Mochi gets real credit for staffing board-certified obesity-medicine physicians rather than general practitioners. That distinction matters. A clinician trained specifically in metabolic disease manages your titration differently than one who sees weight loss as a side consult. Compounded semaglutide at $99 a month and tirzepatide at $199 a month sit well below most competitors on a monthly-cost basis, and the three-month and twelve-month commitment tiers lower the price further. Monitoring is more clinical than most cash-pay programs at this price point.
After the March 2026 settlement between Novo Nordisk and several telehealth platforms, Hims & Hers stopped offering compounded GLP-1s to new patients entirely. New starts now go straight to branded Wegovy or Zepbound. Injectable Wegovy is listed at roughly $299 a month. Oral Wegovy runs about $249. Zepbound lands around $399. Those prices look steep on paper, but commercial insurance paired with manufacturer savings cards can bring the monthly cost down to nearly nothing for eligible patients. The interface is clean and getting started takes minutes. If you want branded meds and a slick interface, this works. If you want compounded options or a peptide stack, look elsewhere.
Ro’s real strength is insurance support. They have a dedicated prior-authorization team, which is more than most telehealth platforms bother to staff. The membership structure can feel a little layered since the $149-a-month figure does not include medication, but for patients with insurance who keep hitting walls trying to get a GLP-1 covered, Ro’s support infrastructure is worth the friction.
Speed is the product here. Henry Meds routinely ships within 24 to 72 hours of intake approval. First-month pricing runs roughly $179 to $249. The tradeoff is ongoing clinical monitoring that is lighter than what you get at Mochi or Form Health. Fine for someone who wants medication and minimal friction. Less ideal for someone with metabolic complexity.
PlushCare’s model is closer to a traditional telehealth primary-care platform than a weight-loss program. The monthly membership is about $19.99, and from there you pay per visit and per prescription. Insurance is accepted, same-day appointments are available, and the focus is entirely on branded FDA-approved medications: Ozempic, Wegovy, Mounjaro. No compounded options, no peptides, no behavior coaching baked in. Efficient. Narrow.
Calibrate bets heavily on behavior change alongside medication. The program requires a twelve-month commitment, and the program fee is separate from whatever the medication costs. That structure rewards patience and insured patients who want structured coaching. It is a poor fit for cash-pay patients who want flexibility.
Eden runs a straightforward cash-pay compounded semaglutide program at around $149 a month. No elaborate coaching layer, no membership stacked underneath. For someone who knows what they want, has already done their research, and just needs a simple dispensing pathway, the model makes sense. Less clinical depth than Mochi; lower price than most branded options.
Form Health is the premium end of the market. About $299 a month for the program, plus labs, plus medication on top. What you get is a physician and a registered dietitian working together on your case, which is genuinely differentiated from platforms where a clinician approves a prescription and disappears. The cost structure rules out most patients without strong insurance or a high discretionary budget. For those it fits, the depth of clinical attention is real.

“GLP-1 value” means different things depending on your situation. If insurance is in the picture and you want branded medications with support getting coverage sorted, Ro or Hims & Hers make the most sense. If clinical depth and affordable compounded pricing matter most, Mochi is hard to beat at its tier. If you are cash-pay and want a single physician-supervised source that covers GLP-1 compounds alongside a broader catalog with published purity data and no membership layered over the medication price, FormBlends earns the top position in this list.
The 2026 FDA warning letters to over thirty telehealth companies made one thing clear: not all compounding programs are the same. Supply chain shortcuts and vague quality claims are real problems in this market. Published lab numbers from named testing methods are not a luxury. They are the baseline.
Before starting any prescription medication or compounded compound, speak with a physician who has access to your full health history. The rankings here reflect independent editorial opinion based on publicly available information as of mid-2026.
[internal: placement #1 | structure: Comparison-led, big table, scoring]